3
Shared Docs
3
Same-Page
3 / 3
Mentions
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
closing party EFTA01467816 or a jurisdiction that may not necessarily provide an equivalent or adequate level of protection for personal data as the disclosing party's home jurisdiction." MISCELLANEOUS. This First Amendment constitutes the entire agreement and understanding of the parties with respect to the sub
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
hat of the disclosing party or a jurisdiction that may not necessarily provide an equivalent or adequate level of protection for personal data as the disclosing party's home jurisdiction." MISCELLANEOUS. This First Amendment constitutes the entire agreement and understanding of the parties with respect to the sub
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
hat of the disclosing party or a jurisdiction that may not necessarily provide an equivalent or adequate level of protection for personal data as the disclosing party's home jurisdiction." MISCELLANEOUS. This First Amendment constitutes the entire agreement and understanding of the parties with respect to the sub
Entities connected to both the Council on OTC derivatives and the disclosing party's